ANHUI MENOVO (NINGBO MENOVO)
About ANHUI MENOVO (NINGBO MENOVO)
Certifications
Categories
-
CN
-
2022On CPHI since
-
2Certificates
-
1000 - 4999Employees
Company types
Primary activities
Meet us at
CPHI Frankfurt 2025
Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025
Products from ANHUI MENOVO (NINGBO MENOVO) (5)
-
Product Atorvastatin Ca
Status: Commercial; Specification: EP,USP,CP;Submission of Regulations: EDMF, CEP, USDMF under preparing, CDMF. -
Product Losartan Potassium
Status: Commercial; Specification: EP, CP; Submission of Regulations: EDMF, CEP, USDMF, CDMF -
Product Pregabalin
Status: Commercial; Specification: EP, CP; Submission of Regulations:CEP under preparing, CDMF -
Product Rosuvastatin Ca
Status: Commercial; Specification: EP, USP, CP; Submission of Regulations: EDMF, CEP, USDMF, CDMF. -
Product Valsartan
Status: Commercial; Specification: EP,USP;Submission of Regulations:EDMF, CEP, USDMF, CDMF.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance